Group One Trading, L.P. Alkermes Plc. Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

A detailed history of Group One Trading, L.P. transactions in Alkermes Plc. stock. As of the latest transaction made, Group One Trading, L.P. holds 1,245 shares of ALKS stock, worth $34,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,245

Previous 1,958 36.41%

Holding current value

$34,648

Previous $53,000 43.4%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $16,548 - $19,422	-713 Reduced 36.41%	1,245 $30,000
Q1 2024 May 10, 2024	BUY	$26.4 - $32.56 $51,691 - $63,752	1,958 New	1,958 $53,000
Q3 2023 Nov 09, 2023	BUY	$27.17 - $31.97 $134,573 - $158,347	4,953 Added 76.01%	11,469 $321,000
Q2 2023 Aug 09, 2023	SELL	$28.34 - $33.63 $410,930 - $487,635	-14,500 Reduced 69.0%	6,516 $203,000
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $119,817 - $137,380	4,734 Added 29.08%	21,016 $592,000
Q4 2022 Feb 09, 2023	SELL	$21.94 - $26.24 $558,197 - $667,598	-25,442 Reduced 60.98%	16,282 $425,000
Q3 2022 Nov 09, 2022	BUY	$22.0 - $31.87 $917,928 - $1.33 Million	41,724 New	41,724 $932,000
Q1 2022 May 12, 2022	SELL	$23.07 - $27.99 $13,242 - $16,066	-574 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$21.47 - $32.08 $195,634 - $292,312	-9,112 Reduced 94.07%	574 $13,000
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $226,361 - $311,211	9,686 New	9,686 $299,000
Q2 2021 Aug 10, 2021	SELL	$18.78 - $25.15 $650,933 - $871,724	-34,661 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$18.21 - $23.2 $91,669 - $116,788	5,034 Added 16.99%	34,661 $647,000
Q4 2020 Feb 10, 2021	SELL	$15.39 - $22.1 $19,791 - $28,420	-1,286 Reduced 4.16%	29,627 $591,000
Q3 2020 Nov 12, 2020	BUY	$16.16 - $20.66 $42,209 - $53,963	2,612 Added 9.23%	30,913 $512,000
Q2 2020 Aug 13, 2020	BUY	$13.31 - $19.41 $358,544 - $522,866	26,938 Added 1976.38%	28,301 $549,000
Q1 2020 May 13, 2020	SELL	$13.06 - $21.24 $169 - $276	-13 Reduced 0.94%	1,363 $20,000
Q4 2019 Feb 10, 2020	BUY	$17.29 - $21.74 $15,803 - $19,870	914 Added 197.84%	1,376 $28,000
Q3 2019 Nov 12, 2019	BUY	$19.51 - $24.28 $6,145 - $7,648	315 Added 214.29%	462 $9,000
Q2 2019 Aug 09, 2019	BUY	$21.47 - $37.33 $3,156 - $5,487	147 New	147 $3,000
Q1 2019 May 13, 2019	SELL	$28.4 - $36.49 $69,949 - $89,874	-2,463 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$27.94 - $44.61 $128,132 - $204,581	-4,586 Reduced 65.06%	2,463 $73,000
Q3 2018 Nov 08, 2018	SELL	$38.6 - $46.12 $182,809 - $218,424	-4,736 Reduced 40.19%	7,049 $299,000
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $88,826 - $112,478	-2,190 Reduced 15.67%	11,785 $485,000
Q1 2018 May 11, 2018	BUY	$53.61 - $67.26 $749,199 - $939,958	13,975 New	13,975 $810,000
Q4 2017 Feb 09, 2018	SELL	$47.69 - $55.39 $171,493 - $199,182	-3,596 Closed	0 $0
Q3 2017 Nov 15, 2017	SELL	$49.16 - $54.45 $173,633 - $192,317	-3,532 Reduced 49.55%	3,596 $183,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,128	7,128 $413,000

Others Institutions Holding ALKS

# of Institutions

346

Shares Held

183M

Call Options Held

209K

Put Options Held

89.4K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.57B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Alkermes Plc. Transaction History